ATECAlphatec Holdings, Inc.

$9.43

Price

$9.43-37%1Y
1M+15%1Y-37%

Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.

Smart Score

Below average
4/10
Value23
Quality59
Momentum43
Growth62
Strongest Growth, weakest Value · ranked vs Healthcare peers. The five questions below judge the company on its own terms.
What they do

We are a medical technology company, headquartered in Carlsbad, California, focused on the design, development, and advancement of technology for better surgical treatment of spine disorders. By applying our unique, 100% spine focus and deep industry know-how, we aim to revolutionize spine surgery through clinical distinction. The sophisticated approaches that we create from the ground up integrate with our expanding InformatiX™ ("IX") platform to objectively inform surgery and achieve the goals of spine surgery more predictably and more reproducibly.

In the company’s own words · 10-K filed Feb 24, 2026 · SEC EDGAR

P/E (TTM)-
Market Cap$1.35B
1Y Return-37%
5Y Return-37%

Business segments

Q1 2022 · $70.9M

The company’s own SEC segment disclosure.

  • Products And Services$70.9M100%
  • International Supply Agreement$15.0K0%

Alphatec Holdings, Inc. (ATEC) reported revenue of $214M in Q2 2026 (quarter ended June 30, 2026), up 15% from the same quarter a year earlier. That came with a gross margin of 72% and net loss of $26M. For the full year FY2025, revenue was $764M (+25% year on year) and net income −$143M. Its largest product in 2022-Q1 was Products And Services at $71M, 100% of the disclosed total, just ahead of International Supply Agreement at 0.0%.

Raw charts

10 series · TTM

As reported to the SEC, without any scoring.